1. Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease
   Qiannan Ren et al, 2024, Autophagy CrossRef
2. An integrative approach to assessing effects of a short-term Western diet on gene expression in rat liver
   Jaclyn E. Welles et al, 2022, Frontiers in Endocrinology CrossRef
3. Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives
   Christina-Maria Flessa et al, 2021, Current Obesity Reports CrossRef
4. Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis
   Gwang-woong Go, 2015, Nutrients CrossRef
5. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease
   Cong Liu et al, 2017, World Journal of Gastroenterology CrossRef
6. Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD
   Klaudia Sztolsztener et al, 2021, International Journal of Molecular Sciences CrossRef
7. Effect of Short- and Long-Term High-Fat Feeding on Autophagy Flux and Lysosomal Activity in Rat Liver
   Z. PAPÁČKOVÁ et al, 2012, Physiological Research CrossRef
8. Lipid metabolism, inflammation, and foam cell formation in health and metabolic disorders: targeting mTORC1
   So Yeong Cheon et al, 2021, Journal of Molecular Medicine CrossRef
9. Inhibition of adenosine deaminase and xanthine oxidase by valproic acid abates hepatic triglyceride accumulation independent of corticosteroids in female rats treated with estrogen–progestin
   Tolulope Eniola Omolekulo et al, 2018, Canadian Journal of Physiology and Pharmacology CrossRef
10. An Intimate Relationship between ROS and Insulin Signalling: Implications for Antioxidant Treatment of Fatty Liver Disease
    Aurèle Besse-Patin et al, 2014, International Journal of Cell Biology CrossRef
11. A network-based computational and experimental framework for repurposing compounds toward the treatment of non-alcoholic fatty liver disease
    Danae Stella Zareifi et al, 2022, iScience CrossRef
12. ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets
    Caroline C. Duwaerts et al, 2022, Frontiers in Molecular Biosciences CrossRef